Our pilot grant proposal to examine the differential expression level of cell mechanotype regulating genes in human breast cancer tissue microarray was awarded from the UNM Comprehensive Cancer Center.
Thank you UNMCCC and we are very excited to conduct this research!
Dr. Kim attended to the US-KOREA Conference on Science, Technology, and Entrepreneurship (UKC) 2022. He served as a Symposium Co-Chair of the "Medical Science, Pharmaceutical Science, Veterinary Medicine, Physical Education (MPS)" as well as served as a Session Chair of the MPS "KASBP Session: Metabolism in health and diseases". In his session, he also presented his work entitled "Regulatory role of glucose on cancer cell mechanotype and motility".
August 17-20, 2022
Hyatt Regency Crystal City, Arlington, VA
Dr. Kim was selected as one of the 2022 Fellows in the Transdisciplinary Research on Energetics and Cancer (TREC) Training Workshop.
It was a truly informative workshop and we learned a lot about energy balance, exercise, nutrition, behavioral changes, etc. regarding cancer prevention, treatment, and survivorship.
Also, meeting lots of new and good colleagues was a big bonus!
June 19-24, 2022
Water's Edge Resort & Spa, Westbrook, CT
Dr. Oh presented her work at the Annual Pathology Research Day hosted by the Department of Pathology at the University of New Mexico.
Mijung discovered that cellular mechanotypes of breast cancer cells, such as deformability and contractility, are altered by different extracellular glucose levels. Such changes in mechanotype are mediated through F-actin remodeling and actomyosin contractility and ultimately affect cell motility. More details will be available when the manuscript is published. Stay tuned!
Thu 5/12/2022 3:00 PM - 6:00 PM
Crowne Plaza Hotel - New Mexico Ballroom
Pleased to announce that Dr. Kim was selected as a mentored PI (mPI) within the Autophagy, Inflammation and Metabolism (AIM) Center of Biomedical Research Excellence (CoBRE) at the University of New Mexico. The awarded mPI Research Project will be funded in the amount of $171K during the award period until August 2022 with conditional renew in the following years. Thank you so much for this opportunity and we are very excited to work on the project!
Dr. Kim was awarded a voucher from the IDeA National Resource for Quantitative Proteomics. We are very excited to conduct a proteomics analysis by using this voucher program!
We thank the sponsor and we are happy to announce that Dr. Kim has been awarded METAvivor Early Career Investigator Grant for the study of cancer and immune cell mechanotypes, aiming to improve immunotherapy in metastatic breast cancer.
Aug. 24, 2020
The Kim Lab was officially established in August of 2020.